Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKanabo Grp Plc Regulatory News (KNB)

  • This share is currently suspended. It was suspended at a price of 0.225

Share Price Information for Kanabo Grp Plc (KNB)

Share Price is delayed by 15 minutes
Get Live Data
0.225    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £1.42m
KNB Live PriceLast checked at - London Stock Exchange

Intraday Kanabo Grp Plc Share Chart

Block listing Interim Review

23 Feb 2022 07:00

RNS Number : 4898C
Kanabo Group PLC
23 February 2022
Β 

Kanabo Group Plc

("Kanabo" or the "Company")

Β 

Block Listing Six Monthly Return

Β 

Lapse of Warrants

Β 

Extension of Warrants

Β 

Kanabo Group Plc (LSE:KNB) announces that 8,277,344 RTO warrants (exercisable at 10p) have been exercised since the Company's IPO in February last year. This means that the Company received an additional Β£827,734.

Β 

3,493,937 RTO warrants have now lapsed with effect from 16 February 2022.

Β 

Kanabo makes the following notification pursuant to its existing block admission.

Β 

Name of applicant:

Kanabo Group Plc

Name of scheme:

SOP RTO Warrants

Period of return:

From:

22/1/22

To:

16/2/22

Balance of unallotted securities under scheme(s) from previous return:

9,558,672

Plus:Β  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0

Less:Β  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

3,135,961

Equals:Β  Balance under scheme(s) not yet issued/allotted at end of period:

6,422,711

(These remaining warrants have now lapsed with the exception of 2,928,779 details can be found below)

Β 

Name of applicant:

Kanabo Group Plc

Name of scheme:

SOP RTO Warrants

Period of return:

From:

22/7/21

To:

22/1/22

Balance of unallotted securities under scheme(s) from previous return:

10,953,547

Plus:Β  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0

Less:Β  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

1,394,875

Β 

Equals:Β  Balance under scheme(s) not yet issued/allotted at end of period:

9,558,672

Β 

Β 

Β 

Name of contact:

Peterhouse Capital

Telephone number of contact:

+44 (0) 20 7469 0932

Β 

The Company confirms that the effective expiry date of 2,928,779 RTO warrants has been extended from 16 February 2022 until 15 May 2022, in accordance with the terms of the corresponding warrant instrument as they apply to PDMRs and other insiders. As was foreseen when the warrant instrument was prepared, the Company is in a closed period in the lead-up to the original expiry date of the warrants.

Β 

Β 

For further information, please visit http://www.kanabogroup.com / or contact the following:

Β 

Kanabo Group Plc

Via Vox Markets

Meirav Horn, CFO

Peterhouse Capital Ltd (Financial Adviser)

Tel: +44 (0)20 7469 0930

Eran Zucker / Guy Miller

Β 

Peterhouse Capital Ltd (Corporate Broker)

Tel: +44 (0)20 7469 0930

Lucy Williams / Charles Goodfellow

Vox Markets (Investor Relations)

KanaboGroup@voxmarkets.co.uk

Kat Perez

kperez@voxmarkets.co.uk

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
BLRFFFILFLIFFIF
Date   Source Headline
11th Dec 202511:30 amRNSDisposal of Subsidiary: The GP Service Limited
28th Nov 20254:02 pmRNSAppointment of Joint Administrators
1st May 20257:30 amRNSSuspension - Kanabo Group plc
30th Apr 20252:47 pmRNSTemporary suspension of listing
4th Apr 20254:20 pmRNSBusiness Update
24th Mar 202511:02 amRNSResignation of Director
4th Mar 20257:00 amRNSRevenue Growth, Trading and Operational Update
6th Jan 20257:00 amRNSDirectorate Change
31st Oct 20249:48 amRNSCorrection Director/PDMR Shareholding
29th Oct 202411:39 amRNSDirector/PDMR Shareholding
30th Sep 20242:50 pmRNSHalf-year Report
28th Aug 20242:31 pmRNSDirector/PDMR Shareholding
27th Jun 20244:49 pmRNSResult of AGM
4th Jun 20247:00 amRNSExpansion:14 New Clinics Partnership with Treat-It
31st May 202410:30 amRNSNotice of AGM
30th Apr 20242:15 pmRNSAnnual Financial Report
28th Mar 20247:00 amRNSExpansion of Treat It to Mental Health Treatments
27th Mar 20245:11 pmRNSHolding(s) in Company
25th Mar 20247:00 amRNSGermany Medical Cannabis Legislation Reform
18th Mar 20249:14 amRNSAgritec Update
15th Jan 20247:00 amRNSPartnership to launch a Walk-In Pain Clinic
14th Nov 20237:00 amRNSContract Extension With Major UK Retailer
2nd Nov 20237:00 amRNSPartnership with BRITISH CANNABISâ„¢
29th Sep 20237:00 amRNSHalf-Year Results
31st Aug 202311:13 amRNSTotal Voting Rights
11th Aug 202311:36 amRNSIssuance of New Ordinary Shares and TVR
26th Jul 20232:00 pmRNSAdmission and Total Voting Rights
24th Jul 20234:10 pmRNSIssuance of New Ordinary Shares and TVR
17th Jul 20237:00 amRNSSuccess for Kanabo Agritec with Contract Award
10th Jul 202311:19 amRNSIssue of New Ordinary Shares and TVR
30th Jun 20232:34 pmRNSResult of AGM
28th Jun 20237:00 amRNSIssue of New Ordinary Shares and TVR
23rd Jun 20237:00 amRNSGrant of Options
13th Jun 20232:39 pmRNSPublication of a Prospectus
8th Jun 20235:19 pmRNSNotice of Annual General Meeting
31st May 202311:30 amRNSTotal Voting Rights
26th May 202310:30 amRNSTotal Voting Rights
23rd May 202311:00 amRNSIssuance of New Ordinary Shares
16th May 20233:00 pmRNSUpdate: Amendments to Acquisition Agreement
16th May 20237:00 amRNSAmendments to Acquisition Agreement
15th May 20237:00 amRNSTotal Voting Rights
12th May 20237:00 amRNSTotal Voting Rights
10th May 20232:52 pmRNSResult of Broker Option
9th May 20237:00 amRNSAppointment of Ian Mattioli as Non-Executive Chair
9th May 20237:00 amRNSFundraise of £2.54 million and Broker Option
4th May 20234:45 pmRNSBoard Change
2nd May 20237:00 amRNSFull Year Results 2022
31st Mar 20232:40 pmRNSDirectorate Change
13th Mar 20237:00 amRNSTreat It Launch: Online Medicinal Cannabis Clinic
7th Mar 202312:15 pmRNSAppointment of Auditor

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.